← Leaderboards
Joseph Paul Broderick
University Of Cincinnati
$95,619,410
Attributed
$152,879,912
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $21.5M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$170,025,822 · 14
By mechanism
U01$113,122,590 · 5
R01$35,925,486 · 4
P50$19,062,232 · 3
T32$1,702,533 · 1
R34$212,981 · 1
Top collaborators
- Pooja Khatri9 shared
- James C Grotta8 shared
- Jordan J. Elm5 shared
- Hooman Kamel5 shared
- Wt Longstreth5 shared
- Caitlyn N Meinzer5 shared
- Andrew M Naidech5 shared
- David L Tirschwell5 shared
Most similar at University Of Cincinnati
Same institution · by research overlap
- Arthur Martin Pancioli$5,338,859
- James C Grotta$18,042,423
- Mathew Flathery$3,497,315
- George Jerome Shaw$840,984
- Andrew M Naidech$10,150,469
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
- Walter N Kernan · Yale University$53,085,019
Research focus
StrokeNational Institute Of Neurological Disorders And StrokeClinical ResearchDesignSiteAcuteEnrollmentHuman SubjectResearch PersonnelIncidenceClinical TrialsCostAlteplaseImagePreventionProgramsRehabilitation TherapyIschemic StrokeAcute StrokeRandomizedRecruitHospitalsCerebral HemorrhageInnovation
Grant awards (92)
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial$4,412,639
U01 · FY2025 · NS · contact PI
NIH StrokeNet National Clinical Coordinating Center (NCC)$2,455,413
U01 · FY2025 · NS · contact PI
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial$4,827,459
U01 · FY2024 · NS · contact PI
NIH StrokeNet National Clinical Coordinating Center (NCC)$2,863,371
U01 · FY2024 · NS
NIH StrokeNet National Clinical Coordinating Center$160,380
U01 · FY2024 · NS · contact PI
NIH StrokeNet National Clinical Coordinating Center$105,841
U01 · FY2024 · NS · contact PI
Making Acute Stroke Trials Succeed: Challenges and Potential Solutions$56,700
U01 · FY2024 · NS · contact PI
Cerebrovascular Fellowship Training Program$1
T32 · FY2024 · NS · contact PI
NIH StrokeNet National Clinical Coordinating Center$2,389,774
U01 · FY2022 · NS · contact PI
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$2,310,548
U01 · FY2022 · NS
Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial$6,997,609
U01 · FY2021 · NS
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial$5,130,446
U01 · FY2021 · NS · contact PI
NIH StrokeNet National Clinical Coordinating Center$2,391,379
U01 · FY2021 · NS · contact PI
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$1,790,846
U01 · FY2021 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$6,861,083
U01 · FY2020 · NS
FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial$6,472,265
U01 · FY2020 · NS · contact PI
Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial$5,800,999
U01 · FY2020 · NS
NIH StrokeNet National Clinical Coordinating Center$2,393,054
U01 · FY2020 · NS · contact PI
NIH StrokeNet National Clinical Coordinating Center$2,417,137
U01 · FY2019 · NS · contact PI
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$6,959,908
U01 · FY2018 · NS
Multi-arm Optimization of Stroke Thrombolysis (MOST) Stroke Trial$5,966,429
U01 · FY2018 · NS
NIH StrokeNet National Clinical Coordinating Center$2,489,388
U01 · FY2018 · NS · contact PI
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$4,072,827
U01 · FY2017 · NS
NSTN National Clinical Coordinating Center$2,361,126
U01 · FY2017 · NS · contact PI
NSTN National Clinical Coordinating Center$2,361,126
U01 · FY2016 · NS · contact PI
NSTN National Clinical Coordinating Center$2,347,302
U01 · FY2015 · NS · contact PI
NSTN National Clinical Coordinating Center$2,367,154
U01 · FY2014 · NS · contact PI
Cerebrovascular Fellowship Training Program$153,446
T32 · FY2014 · NS · contact PI
NSTN National Clinical Coordinating Center$2,472,191
U01 · FY2013 · NS · contact PI
Cerebrovascular Fellowship Training Program$183,446
T32 · FY2013 · NS · contact PI
Recanalization Therapies and Markers of Stroke Outcome$1,559,517
P50 · FY2012 · NS · contact PI
Interventional Management of Stroke Study (IMS III)$1,000,000
U01 · FY2012 · NS · contact PI
Patient Access and Administrative Core$762,153
P50 · FY2012 · NS · contact PI
Cerebrovascular Fellowship Training Program$251,613
T32 · FY2012 · NS · contact PI
Interventional Management of Stroke Study (IMS III)$4,500,088
U01 · FY2011 · NS · contact PI
Recanalization Therapies and Markers of Stroke Outcome$1,607,031
P50 · FY2011 · NS · contact PI
Patient Access and Administrative Core$279,089
P50 · FY2011 · NS · contact PI
Cerebrovascular Fellowship Training Program$247,465
T32 · FY2011 · NS · contact PI
Interventional Management of Stroke Study$5,050,000
U01 · FY2010 · NS · contact PI
Familial Intracranial Aneurysm Study II (FIA II)$4,810,953
R01 · FY2010 · NS · contact PI
Recanalization Therapies and Markers of Stroke Outcome$1,792,178
P50 · FY2010 · NS · contact PI
Patient Access and Administrative Core$224,332
P50 · FY2010 · NS · contact PI
Cerebrovascular Fellowship Training Program$58,964
T32 · FY2010 · NS · contact PI
Familial Intracranial Aneurysm Study II (FIA II)$3,270,460
R01 · FY2009 · NS · contact PI
Recanalization Therapies and Markers of Stroke Outcome$1,791,105
P50 · FY2009 · NS · contact PI
Interventional Management of Stroke Study$587,796
U01 · FY2009 · NS · contact PI
Interventional Management of Stroke Study$335,100
U01 · FY2009 · NS · contact PI
Patient Access and Administrative Core$214,041
P50 · FY2009 · NS · contact PI
Cerebrovascular Fellowship Training Program$178,308
T32 · FY2009 · NS · contact PI
Recanalization Therapies and Markers of Stroke Outcome (P50)$158,684
P50 · FY2009 · NS · contact PI
Recanalization Therapies and Markers of Stroke Outcome$111,195
P50 · FY2009 · NS · contact PI
Interventional Management of Stroke Study$3,822,687
U01 · FY2008 · NS · contact PI
Recanalization Therapies and Markers of Stroke Outcome$1,801,855
P50 · FY2008 · NS · contact PI
Cerebrovascular Fellowship Training Program$246,588
T32 · FY2008 · NS · contact PI
Patient Access and Administrative Core$195,831
P50 · FY2008 · NS · contact PI
Interventional Management of Stroke Study$2,000,001
U01 · FY2007 · NS · contact PI
Cerebrovascular Fellowship Training Program$254,805
T32 · FY2007 · NS · contact PI
Familial Intracranial Aneurysm Study$3,431,813
R01 · FY2006 · NS · contact PI
Recanalization Therapies and Markers of Stroke Outcome$1,676,048
P50 · FY2006 · NS · contact PI
Genetic&Environment Risk Factors for Hemorrhagic Stroke$722,211
R01 · FY2006 · NS · contact PI
Cerebrovascular Fellowship Training Program$127,897
T32 · FY2006 · NS · contact PI
Interventional Management of Stroke Study$4,592,524
U01 · FY2005 · NS
Familial Intracranial Aneurysm Study$3,345,691
R01 · FY2005 · NS
Recanalization Therapies and Markers of Stroke Outcome$1,820,523
P50 · FY2005 · NS
Hemorrhagic and Ischemic Stroke Among Blacks and Whites$1,155,952
R01 · FY2005 · NS
Genetic&Environment Risk Factors for Hemorrhagic Stroke$1,110,588
R01 · FY2005 · NS
Familial Intracranial Aneurysm Study$3,250,935
R01 · FY2004 · NS
Recanalization Therapies and Markers of Stroke Outcome$1,498,628
P50 · FY2004 · NS
Genetic&Environment Risk Factors for Hemorrhagic Stroke$1,063,888
R01 · FY2004 · NS
Hemorrhagic and Ischemic Stroke Among Blacks and Whites$989,353
R01 · FY2004 · NS
Interventional Management of Stroke III Planning Grant$212,981
R34 · FY2004 · NS
Recanalization Therapies and Markers of Stroke Outcome$153,500
P50 · FY2004 · NS
Recanalization Therapies and Markers of Stroke Outcome$153,500
P50 · FY2004 · NS
Recanalization Therapies and Markers of Stroke Outcome$153,500
P50 · FY2004 · NS
Recanalization Therapies and Markers of Stroke Outcome$76,750
P50 · FY2004 · NS
Familial Intracranial Aneurysm Study$2,906,040
R01 · FY2003 · NS
Recanalization Therapies and Markers of Stroke Outcome$1,346,635
P50 · FY2003 · NS
Genetic&Environment Risk Factors for Hemorrhagic Stroke$1,072,914
R01 · FY2003 · NS
HEMORRHAGIC AND ISCHEMIC STROKE AMONG BLACKS AND WHITES$67,427
R01 · FY2003 · NS
Familial Intracranial Aneurysm Study$3,541,171
R01 · FY2002 · NS
Recanalization Therapies and Markers of Stroke Outcome$1,445,261
P50 · FY2002 · NS
Genetic /Environment Risk Factors for Hemorrhagic Stroke$1,122,665
R01 · FY2002 · NS
INTERVENTIONAL MANAGEMENT OF STROKE (IMS) STUDY$618,684
R01 · FY2002 · NS
HEMORRHAGIC AND ISCHEMIC STROKE AMONG BLACKS AND WHITES$374,153
R01 · FY2002 · NS
CORE--CAREER DEVELOPMENT CORE$240,876
P50 · FY2002 · NS
INTERVENTIONAL MANAGEMENT OF STROKE (IMS) STUDY$706,641
R01 · FY2001 · NS
HEMORRHAGIC AND ISCHEMIC STROKE AMONG BLACKS AND WHITES$299,291
R01 · FY2001 · NS
HEMORRHAGIC AND ISCHEMIC STROKE AMONG BLACKS AND WHITES$76,500
R01 · FY2001 · NS
INTERVENTIONAL MANAGEMENT OF STROKE (IMS) STUDY$904,845
R01 · FY2000 · NS
HEMORRHAGIC AND ISCHEMIC STROKE AMONG BLACKS AND WHITES$588,317
R01 · FY2000 · NS
GENETIC AND ENVIRONMENTAL RISK FACTORS FOR STROKE$472,044
R01 · FY2000 · NS
HEMORRHAGIC AND ISCHEMIC STROKE AMONG BLACKS AND WHITES$22,950
R01 · FY2000 · NS